Antisense & Rnai Therapeutics Market Growth Accelerated By Increased Adoption Of Personalized Medicine

 
Rnai And Antisense Therapeutics

Antisense & RNAi therapeutics are novel class of drugs that can selectively modulate the production of disease-causing proteins.Theyhelp in preventing or treating a range of clinical conditions such as cancer,cardiovascular diseases, infectious diseases and genetic disorders. The growing demand for personalized medicines worldwide is driving the adoption of these therapeutics that can specifically target a patient's genetic abnormalities. The global Antisense & RNAi Therapeutics Market is estimated to be valued at US$ 6.38 Bn in 2024 and is expected to exhibit a CAGR of 18% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The growing adoption of personalized medicine worldwide is one of the key trends driving the growth of the antisense & RNAi therapeutics market. Personalized medicine involves tailoring medical treatment to an individual based on their genetic makeup and disease profile. It helps provide targeted treatment by developing drugs that can precisely modulate the expression of genes causing diseases. As antisense & RNAi therapeutics can specifically control gene expression at the RNA level, they are increasingly being used to develop personalized treatment options. The success of some clinically approved antisense & RNAi drugs has demonstrated their potential for precision medicine, fueling increased R&D and adoption of these novel therapeutics over the forecast period.

Segment Analysis
The global Antisense & RNAi Therapeutics market is dominated by cancer which accounts for around 45% of the market share. Cancer sub-segment dominates the overall market as antisense & RNAi therapeutics have shown promising results in cancer treatment by selectively targeting cancer causing genes.

Key Takeaways
The global Antisense & RNAi Therapeutics market demand is expected to witness high growth over the forecast period of 2024 to 2031.

Regional analysis:

North America region currently dominates the global market due to availability of advanced healthcare infrastructure and presence of key players in the region. However, Asia Pacific region is expected to witness fastest growth over the forecast period owing rising healthcare expenditure, increasing research & development activities for developing novel drugs and presence of large patient pool in the region.

Key players

operating in the global Antisense & RNAi Therapeutics market are Benitec Biopharma Inc., Silence Therapeutics, Ionis Pharmaceuticals, Inc., Bio-Path Holdings Inc., Percheron Therapeutics Limited, GSK plc, Olix Pharmaceuticals, Inc., Sanofi, Alnylam Pharmaceuticals, Inc. and Arbutus Biopharma. Ionis Pharmaceuticals is the leading player owing to its strong product portfolio and pipeline molecules in clinical trials.

 

 Get more insights on this topic: https://www.ukwebwire.com/global-antisense-rnai-therapeutics-market-industry-insightstrendsglobal-antisense-rnai-therapeutics-market/

 

Explore more information on this topic, Please visit: https://captionssky.com/footwear-sole-materials-an-analysis-of-modern-trends-and-future-outlook/

Comments

Post a Comment

Popular posts from this blog

The Global Ammonium Nitrate Market Growth Accelerated By Rising Demand From Agriculture Industry

Image
Ammonium Nitrate Market   Ammonium nitrate is an extensively used fertilizer, which is inexpensive and highly effective. It contains nitrogen, a major nutrient needed for plant growth and development. It provides plants with a continuous and balanced supply of nitrogen which helps in increasing crop yields. The ammonium nitrate market is driven by the growing agriculture sector across the globe. The increasing global population has accelerated the demand for food, resulting in high usage of for boosting agricultural production. The global ammonium nitrate market is estimated to be valued at US$ 21.18 Mn in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing demand from agriculture is one of the major trends fueling the growth of the ammonium nitrate market. Agriculture accounts for over 80% of the ammonium nitrate consumption globally....
Read more

The Global Coffee Market Growth Accelerated By Demand From Millennials And Gen Z Population

Image
  Coffee Market  Coffee is a popular beverage consumed worldwide for its stimulant properties and unique flavor. Coffee beans contain caffeine that stimulates the central nervous system and increases energy levels. Major products in the coffee market include whole coffee beans, ground coffee, coffee pods, instant coffee, and canned or bottled coffee. Coffee promotes mental clarity and alertness and offers antioxidant and anti-inflammatory benefits. The global coffee market is estimated to be valued at US$ 132.99 billion in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing demand for coffee from the millennial and Gen Z population is one of the key trends driving the growth of the global coffee market. Millennials and Gen Z are the primary consumers and account for over 50% of total coffee consumption globally. These younger demographics v...
Read more

The Global Cardiopulmonary Bypass Equipment Market Growth Accelerated By Rising Demand For Heart Surgeries

Image
  Cardiopulmonary Bypass Equipment Market  Cardiopulmonary bypass equipment are medical devices that temporarily take over the function of the heart and lungs during surgery, allowing the heart to be stopped. They consist of equipment such as oxygenators, centrifugal pumps, and cardioplegia delivery systems. Such equipment helps divert blood around the heart and provides a stop flow condition during cardiac surgeries, enabling surgeons to perform intricate procedures on a still heart. The global cardiopulmonary bypass equipment market is estimated to be valued at US$120.01 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The rising demand for heart surgeries is one of the major trends fueling the growth of the cardiopulmonary bypass equipment market. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the le...
Read more